University of Washington
Talks (127)
Air Time: 624:16:29
CSRP3 and CRS
Feb 29
NephMadness 2024
Feb 29
SGLT2i and sodium handling
Feb 27
SPRINT data and kidney function
Feb 26
Hyperammonemia in Acute Liver Failure
Feb 26
PLUTO trial
Jan 25
Finerenone in CKD Stage 4
Jan 25
Finerenone + Dapagliflozin in non-DM CKD
Jan 25
Probenacid to augment diuresis
Jan 11
Finerenone and Albuminuria Reduction
Jan 11
Fostamatinib IgA Nephropathy
Dec 21
Daratumumab for Lupus Nephritis
Dec 21
NELL1 Membranous Nephropathy
Dec 21
SPACE Trial
Dec 01
POP-HT trial
Dec 01
Renal Deenervation
Nov 30
Nephrology Match
Nov 29
Pillars of DKD Treatment
Nov 29
Late breaking sessions
Nov 07
ALCHEMIST Study
Nov 07
Serologic guided approach to MN
Nov 07
hypertonic saline
Nov 07
waxy casts
Nov 07
aldosterone synthase inhibitor CKD
Nov 07
terlipressin HRS-AKI
Nov 07
PD in ADHF
Nov 02
ACEi/ARB in dialysis patients
Nov 02
Dietary Potassium and Hemodialysis
Nov 02
Hypertension in DKD
Nov 01
Albuminuria and Heart Failure
Oct 23
LBCT at Kidney Week
Oct 13
GLP-1 agonists and the economy
Oct 13
FLOW Trial
Oct 13
Finerenone in non-diabetic CKD
Sep 29
PUSH-AHF
Sep 29
History of saline
Sep 21
PROTECT TRIAL FILSPARI
Sep 21
IV iron for CKD and Heart Failure
Sep 14
Lorundrostat for HTN
Sep 14
Sodium Bicarbonate and Vascular Function
Aug 31
Dapagliflozin in Dialysis
Aug 31
GLP-1 agonists and MACE
Aug 10
SELECT trial
Aug 10
SGLT2i and natriuresis
Aug 10
baxdrostat
Jul 29
BEST-Fluids
Jul 26
Zilebesiran and Hypertension
Jul 20
RAAS activation during decongestion
Jul 19
Heart/Kidney Safety Net
Jul 13
Thiazides and Glucose Intolerance
Jul 13
Arkana labs APOL1
Jun 29
ENACT-HF
Jun 29
PAPi and diuretic resistance
Jun 09
Spironolactone in cirrhosis
Jun 09
DKD and the Boston Red Sox?
Jun 07
DAPA-RESIST diuretic resistance
May 23
Natriuresis and Outcomes ADVOR
May 19
lactic acid and outcomes
May 15
Flozins and eGFR stratification
May 15
US in cirrhosis
May 15